Navigation Links
Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn
Date:10/8/2007

SANTA MONICA, Calif., Oct. 8 /PRNewswire-USNewswire/ -- Proposed regulations that would govern who owns and controls discoveries resulting from California stem cell research grants to for-profit organizations fail to ensure affordable access to the drugs and cures for California taxpayers paying for the research, the Foundation for Taxpayer and Consumer Rights (FTCR) said today.

"To ensure that the people who have paid for the research to develop these drugs have this affordable access, there must be a provision allowing for intervention by the state attorney general if the drugs are priced unreasonably," wrote John M. Simpson, FTCR Stem Cell Project director, in comments filed with the California Institute for Regenerative Medicine (CIRM).

Read FTCR's comments here: http://www.consumerwatchdog.org/resources/FTCRIPcomment100507.pdf .

The regulations are being reviewed through the state's Office of Administrative Law and will have the full force of law when completed. The most recent proposal was open for public comment and those comments must be considered before the regulations can be implemented.

FTCR also said that a provision in the proposed Intellectual Property (IP) Regulations for For-Profit Organizations that would have tied some stem cell cure prices to the California Prescription Discount Drug Program, (Cal-Rx) was rendered meaningless by Gov. Arnold Schwarzenegger's action on the state budget. In the deal that allowed the state budget to be approved, Schwarzenegger line-item vetoed the money that would have implemented Cal-Rx.

"Clearly, any provisions in the IP policies that intend to implement favorable pricing must rely entirely on the IP regulations under CIRM's auspices and not on some outside scheme that is highly subject to political whim," wrote Simpson.

Simpson wrote that the revised regulations were clearer and less ambiguous than an early version. He added, "Sadly, however, if the proposed regulations lack an essential provision - in this case a provision that guarantees affordable access for all Californians - it matters little how clear they are."

Proposition 71, passed in 2004, creates a $6 billion stem cell research program and the California Institute for Regenerative Medicine to oversee it. So far CIRM's oversight committee has approved about $210 million in research, training and facilities grants. Last week the state sold the first $250 million in bonds to finance the research program.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org and http://www.oilwatchdog.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Revised Pregnancy Counselling Item Still Flawed
2. Royal College Issues Revised Guidelines for Face Transplantation
3. Government Allot More Funds for Revised TB Program
4. Revised Cholesterol Guidelines Causes Concern Among Medical Community
5. Uttar Pradesh to Declare Revised Medical Entrance Results
6. Passive smoking declared as Toxic in California
7. California Employers may need to Fork out more on Health Benefits
8. An urgent need for prison reforms: California!
9. Death by Smog in California
10. PE Minimums Violations:California Schools Blamed
11. California: Go Ahead For Drug Discount Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... ... as a Service (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) ... channel partners to offer real-time business intelligence (BI) to their small and medium ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a family owned ... Texas, is launching a cooperative charity drive with the Tarrant Area Food Bank in ... 50,000 individuals and families in need, the Tarrant County Food Bank offers hope and ...
(Date:2/12/2016)... San Ramon, CA (PRWEB) , ... February 12, 2016 , ... ... tissue donation in northern California and Nevada, announced a partnership with San Ramon Regional ... be transferred to the hospital’s facilities as a way to accommodate a more certain ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mediaplanet today announces the launch ... component of “Revolutionizing Cancer Care” is distributed within the February 12 issue of ... a circulation of approximately 250,000 copies and an estimated readership of 750,000 readers. ...
(Date:2/12/2016)... ... ... US Sport Camps is pleased to announce the addition of junior golf ... the host site and directing the camps is PGA Professional and 2008 Iowa State ... recent years around Des Moines and are fortunate to have such a well-respected instructor ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 2016 --> ... Inflammation Global Clinical Trials Review, H2, 2015 provides ... clinical trials landscape along with top level data ... (G7 & E7), Trial Status, Trial Phase, Sponsor ... companies involved and enlists all trials (Trial title, ...
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
(Date:2/11/2016)... PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results ... The Company also filed its Quarterly Report on Form 10-Q ... Securities and Exchange Commission today. --> ... --> --> Net sales for the ... 95%, to $5.4 million from $2.8 million for the three ...
Breaking Medicine Technology: